Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Jan Storek & Julian Lindsay. (2023) Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?. Bone Marrow Transplantation.
Crossref
Crossref
Alaa Atamna, Dafna Yahav & Cédric Hirzel. (2023) Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients. Transplant International 36.
Crossref
Crossref
Michelle Lee, Aseala Abousaud, R. Andrew Harkins, Ellen Marin, Deepali Balasubramani, Michael C. Churnetski, Deniz Peker, Ankur Singh & Jean L. Koff. (2023) Important Considerations in the Diagnosis and Management of Post-transplant Lymphoproliferative Disorder. Current Oncology Reports 25:8, pages 883-895.
Crossref
Crossref
Jingmei Hsu, Koen Van Besien, Marshall J. Glesby, Savita Pahwa, Anne Coletti, Meredith G. Warshaw, Lawrence D. Petz, Theodore B. Moore, Ya Hui Chen, Suresh Pallikkuth, Adit Dhummakupt, Ruth Cortado, Amanda Golner, Frederic Bone, Maria Baldo, Marcie Riches, John W. Mellors, Nicole H. Tobin, Renee Browning, Deborah Persaud, Yvonne Bryson, Patricia Anthony, Frederic Bone, Renee Browning, Yvonne Bryson, Anne Coletti, Marshall J. Glesby, Amanda Golner, Rohan Hazra, Jingmei Hsu, Ronald Mitsuyasu, Theodore B. Moore, Savita Pahwe, Deborah Persaud, Lawrence Petz, Nicole H. Tobin, Meredith G. Warshaw & Dwight Yin. (2023) HIV-1 remission and possible cure in a woman after haplo-cord blood transplant. Cell 186:6, pages 1115-1126.e8.
Crossref
Crossref
Chandni Patel, Michelle Pasciolla, Rachel Abramova, David Salerno, Alexandra Gomez-Arteaga, Tsiporah B. Shore, Nina Orfali, Sebastian Mayer, Jingmei Hsu, Adrienne A. Phillips, Ok-Kyong Chaekal, Michael J. Satlin, Rosemary Soave, Rosy Priya L. Kodiyanplakkal, Alexander Drelick, Markus Plate & Koen Van Besien. (2023) Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and Cellular Therapy 29:2, pages 132.e1-132.e5.
Crossref
Crossref
Shuji Mitsuhashi, Divya Chalikonda, Bushra Nazir, Amit Agarwal & Robert Coben. (2022) Recurrent bleeding duodenal and colonic ulcers due to post-transplant lymphoproliferative disorder. Clinical Journal of Gastroenterology 16:1, pages 39-42.
Crossref
Crossref
Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno & Federica Cavallo. (2022) Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of Clinical Medicine 11:24, pages 7542.
Crossref
Crossref
Ok-kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, Rosemary Soave, Tsiporah Shore, Sebastian Mayer, Adrienne Phillips, Jing Mei Hsu, Alexander Drelick, Rosy Priya L. Kodiyanplakkal, Markus Plate, Michael J. Satlin & Koen van Besien. (2022) Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation. Transplantation and Cellular Therapy 28:9, pages 618.e1-618.e10.
Crossref
Crossref
Xiya Wei, Yiyu Xie, Ruoyu Jiang, Huiyu Li, Heqing Wu, Yuqi Zhang, Ling Li, Shiyuan Zhou, Xiao Ma, Zaixiang Tang, Jun He, Depei Wu & Xiaojin Wu. (2022) The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study. Frontiers in Immunology 13.
Crossref
Crossref
Julian Lindsay, Jad Othman, Madeleine R. Heldman & Monica A. Slavin. (2021) Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes. Current Opinion in Infectious Diseases 34:6, pages 635-645.
Crossref
Crossref
Michael J Satlin, Liang Chen, Claire Douglass, Michael Hovan, Emily Davidson, Rosemary Soave, Marisa La Spina, Alexandra Gomez-Arteaga, Koen van Besien, Sebastian Mayer, Adrienne Phillips, Jing-Mei Hsu, Rianna Malherbe, Catherine B Small, Stephen G Jenkins, Lars F Westblade, Barry N Kreiswirth & Thomas J Walsh. (2021) Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clinical Infectious Diseases 73:7, pages 1257-1265.
Crossref
Crossref
Gang Feng, Qing Li, Haibo Zhu, Yanyu Jiang, Jijun Yuan, Yingxin Fu & Qi Deng. (2021) Safety and Efficacy of Anti-CD19-Chimeric Antigen Receptor T Cell Combined With Programmed Cell Death 1 Inhibitor Therapy in a Patient With Refractory Post-Transplant Lymphoproliferative Disease: Case Report and Literature Review. Frontiers in Oncology 11.
Crossref
Crossref
Alastair Baker, Esteban Frauca Remacha, Juan Torres Canizales, Luz Yadira Bravo-Gallego, Emer Fitzpatrick, Angel Alonso Melgar, Gema Muñoz Bartolo, Luis Garcia Guereta, Esther Ramos Boluda, Yasmina Mozo, Dorota Broniszczak, Wioletta Jarmużek, Piotr Kalicinski, Britta Maecker-Kolhoff, Julia Carlens, Ulrich Baumann, Charlotte Roy, Christophe Chardot, Elisa Benetti, Mara Cananzi, Elisabetta Calore, Luca Dello Strologo, Manila Candusso, Maria Francelina Lopes, Manuel João Brito, Cristina Gonçalves, Carmen Do Carmo, Xavier Stephenne, Lars Wennberg, Rosário Stone, Jelena Rascon, Caroline Lindemans, Dominik Turkiewicz, Eugenia Giraldi, Emanuele Nicastro, Lorenzo D’Antiga, Oanez Ackermann & Paloma Jara Vega. (2021) Current Practices on Diagnosis, Prevention and Treatment of Post-Transplant Lymphoproliferative Disorder in Pediatric Patients after Solid Organ Transplantation: Results of ERN TransplantChild Healthcare Working Group Survey. Children 8:8, pages 661.
Crossref
Crossref
Laura N. Walti, Catrina Mugglin, Daniel Sidler, Matteo Mombelli, Oriol Manuel, Hans H. Hirsch, Nina Khanna, Nicolas Mueller, Christoph Berger, Katia Boggian, Christian Garzoni, Dionysios Neofytos, Christian Delden & Cédric Hirzel. (2020) Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study. American Journal of Transplantation 21:7, pages 2532-2542.
Crossref
Crossref
Guang-Qiang Meng, Jing-Shi Wang, Yi-Ni Wang, Na Wei & Zhao Wang. (2021) Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. International Immunopharmacology 96, pages 107606.
Crossref
Crossref
Afsaneh Jahangiryan, Maryam Kheirandish, Shahram Samiee, Zohreh Sharifi & Mastaneh Alaei. (2021) Determination of Epstein-Barr virus (EBV) incidence in umbilical cord blood (UCB) and assessment of virus DNA via Real-time PCR. Annals of Cancer Research and Therapy 29:1, pages 114-120.
Crossref
Crossref
Leonardo Javier Arcuri, Samir Kanaan Nabhan, Gisele Loth, Elias Hallack Atta, Michel Oliveira, Samantha Nichele, Renato de Castro Araujo & Carmem Bonfim. (2020) A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia. Biology of Blood and Marrow Transplantation 26:9, pages e222-e226.
Crossref
Crossref
Julian Lindsay, Michelle K. Yong, Matthew Greenwood, David C. M. Kong, Sharon C. A. Chen, William Rawlinson & Monica Slavin. (2020)
Epstein‐Barr
virus related post‐transplant lymphoproliferative disorder prevention strategies in allogeneic hematopoietic stem cell transplantation
. Reviews in Medical Virology 30:4.
Crossref
Crossref
Madhav Seshadri, Genevieve M. Crane & Usama Gergis. (2020) Ofatumumab for post-transplant lymphoproliferative disorder. Hematology/Oncology and Stem Cell Therapy.
Crossref
Crossref
Hiroaki Inoue, Shinya Rai, Hirokazu Tanaka, J. Luis Espinoza, Maiko Komori-Inoue, Hiroaki Kakutani, Shuji Minamoto, Takahiro Kumode, Shoko Nakayama, Yasuhiro Taniguchi, Yasuyoshi Morita, Takeshi Okuda, Yoichi Tatsumi, Takashi Ashida & Itaru Matsumura. (2020) Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy. Viruses 12:4, pages 416.
Crossref
Crossref
Rama Al Hamed, Abdul Hamid Bazarbachi & Mohamad Mohty. (2019) Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transplantation 55:1, pages 25-39.
Crossref
Crossref
Koen van Besien, Andrew Artz, Richard E. Champlin, Danielle GuarneriMichael R. Bishop, Julianne Chen, Usama GergisTsiporah Shore, Hongtao Liu, Gabriela Rondon, Sebastian A. MayerSamer A. Srour, Wendy Stock & Stefan O. Ciurea. (2019) Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood Advances 3:12, pages 1858-1867.
Crossref
Crossref